Navigation Links
Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT)
Date:7/10/2014

BURLINGTON, Mass., July 10, 2014 /PRNewswire/ -- Decision Resources Group finds that while more than three-quarters of surveyed infectious disease (ID) specialists are willing to prescribe Durata's Dalvance (dalbavancin) and The Medicines Company's Orbactiv (oritavancin) for use as OPAT, approximately two-thirds of the respondents reported a willingness to prescribe these agents to their hospital inpatients. However, our findings indicate that nearly two-thirds (64 percent) of OPAT patients are initiated on OPAT following hospital discharge, and most are discharged on OPAT on the same antibiotic they received as inpatients. These findings suggest that new antibiotics looking to gain traction in the OPAT market must gain inclusion on hospital formularies and position themselves as preferred agents in the hospital setting.

Other key findings from the 2014 U.S. TreatmentTrends report entitled Hospital Discharge and Outpatient Parenteral Antimicrobial Therapy (OPAT):

  • ID specialists as key stakeholders in OPAT market: ID specialists are the healthcare providers most frequently involved in identifying a patient for discharge on OPAT; nearly three-quarters (72 percent) of surveyed ID specialists indicated that their hospital requires prior consultation with an ID specialist to evaluate and setup patients for OPAT.
  • Observation rooms/interim facilities for reducing hospital admissions: More than three quarters (82 percent) of surveyed ID specialists indicated that their hospital has facilities for keeping patients requiring short-term monitoring (less than 48 hours) without admitting them to the hospital. Over half of these facilities are used to administer IV antibiotics and can play an important role in decisions about whether to admi
    '/>"/>

SOURCE Decision Resources Group
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Janssen R&D Ireland Announces Agreement with PATH for Early Development of Rilpivirine in Long-Acting Formulation for Potential Prophylactic Intervention
2. Beyond the Headlines: What the FDA Decisions on Extended-release and Long-Acting Opioids Mean for People With Pain
3. WomanCare Global launches Simplant, Long-acting Reversible Contraception, in Chile
4. PROLOR Biotech To Present Preclinical Data On Its Long-Acting Clotting Factor Vlla At 2012 ASH Annual Meeting
5. Study Published In Contraception Evaluates Medical Expenditures For Unintended Pregnancies And Potential Cost Impact Of Increased Use Of Long-Acting Reversible Contraception
6. Purdue Pharma L.P. Comments on FDA Announcement on REMS for Extended-Release and Long-Acting Opioid Analgesics
7. Applegate CEO Worries FDA Plan To Address Antibiotics In Animal Agriculture Is Too Little, Too Late
8. AVMA lauds FDA for new regulation of antibiotics in livestock feed
9. Debiopharm Group and TCG Lifesciences Ltd. Enter into an Exclusive Research Agreement to Develop a Novel Class of Antibiotics, a New Strategic Therapeutic Area for Debiopharm
10. Rising Drug Resistance is Driving Early-Line Use of Powerful Antibiotics Such as Carbapenems for Gram-Negative Infections, According to Surveyed EU5 Physicians
11. Antibiotic Resistance 2013: The Antibiotics Development Pipeline and Strategies to Combat Antibiotic Resistance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... --  Wellcentive , the industry leader in end-to-end ... today being named one of the four finalists ...  Sponsored by Intel, the world leader in computing ... companies developing leading-edge technology and unique approaches to ... Wellcentive,s Mason Beard , senior vice ...
(Date:11/18/2014)... Nov. 18, 2014 Respiratory Motion and IMI ... medical device and services providers in Japan ... Respiratory Motion,s innovative respiratory depression monitor, the ExSpiron™. As ... are working together to connect the clinical community in ... history of bringing innovative medical devices and new technology ...
(Date:11/18/2014)... 18, 2014 Investor-Edge has initiated coverage ... ), Geron Corporation (NASDAQ: GERN ), Tekmira Pharmaceuticals ... GALE ), and XOMA Corporation (NASDAQ: ... accessed at: http://investor-edge.com/register . The US markets ... as the Dow Jones Industrial Average finished at 17,647.75, up ...
Breaking Medicine Technology:Wellcentive Named Finalist for 2014 Intel Innovation Award 2Wellcentive Named Finalist for 2014 Intel Innovation Award 3Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 2Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 3Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 4Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 2Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 3Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 4Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 5
(Date:11/21/2014)... The cost of diabetes care in the United States ... more than $322 billion annually, a new report shows. ... prediabetes care, which have risen 74 percent, and undiagnosed ... In 2012, excess medical costs and lost productivity ... American. That total includes $244 billion in medical costs ...
(Date:11/21/2014)... 2014 Richard Wolfe, co-founder and ... present advanced benefits administration strategies during the Game ... Leadership Summit. This Game Changer breakout session enables ... present cutting-edge solutions and best practices to top ... real-time data exchange between health and welfare benefits ...
(Date:11/21/2014)... Kansas City, Mo (PRWEB) November 21, 2014 ... has received the Get With The Guidelines®–Heart Failure ... improvement measures outlined by the American Heart Association/American ... guidelines for heart failure patients. , Get With ... that helps hospital teams provide the most up-to-date, ...
(Date:11/21/2014)... NJ (PRWEB) November 21, 2014 The ... homemade, high calorie dishes, plenty of gravy and a ... could be the best time of year to begin ... Diet Doc has uncovered the secret to losing unhealthy, ... the fattening holiday recipes. , The insight to Diet ...
(Date:11/21/2014)... Midway through the research period for the 2015 ... of Health Plans, preliminary data shows volatility in the ... is a comprehensive resource with enrollment data and contact ... 2015 edition will be available in February. ... Division, the company’s exclusive in-house research team, have identified ...
Breaking Medicine News(10 mins):Health News:Cost of Diabetes Care Keeps Climbing, Report Shows 2Health News:Empyrean Benefit Solutions CEO Sharing Latest Benefits Administration Strategies with Houston HR Leaders 2Health News:Empyrean Benefit Solutions CEO Sharing Latest Benefits Administration Strategies with Houston HR Leaders 3Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 2Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 3Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 4Health News:Diet Doc Releases New Calorie Loading Diet Plans - the Perfect Way to Jump Start the Metabolism and Begin Weight Loss During Thanksgiving 2Health News:Diet Doc Releases New Calorie Loading Diet Plans - the Perfect Way to Jump Start the Metabolism and Begin Weight Loss During Thanksgiving 3Health News:Diet Doc Releases New Calorie Loading Diet Plans - the Perfect Way to Jump Start the Metabolism and Begin Weight Loss During Thanksgiving 4Health News:Data from Atlantic Information Services’s Forthcoming Directory Shows Volatility in U.S. Health Care Market 2
... , McALLEN, Texas, Dec. 3 The Ensign ... it has acquired three Texas skilled nursing facilities: the ... the 100-bed Alta Vista Rehabilitation & Healthcare in Brownsville; ... The acquisitions were effective December 1, 2009. , (Logo: ...
... , MINNEAPOLIS, Dec. 3 The American Association of Poison ... Minneapolis, Minnesota as an accredited poison control center - a ... AAPCC places the Hennepin Regional Poison Center among 58 accredited ... major accomplishment. It means we have met the national standards ...
... , NEW YORK, Dec. ... is available in its catalogue: , Point of Care ... review and analysis of the point of care (POC) diagnostics ... POC diagnostics industry , Covers federal regulation of POC ...
... , Statement by John Gay, Executive Director and ... to a new campaign launched today by the U.S. ... marketplace of "rogue" marketers selling steroids as dietary supplements, ... association representing retailers and manufacturers of dietary supplements and ...
... finds rising incidence of obesity could counter recent increases in ... health of the U.S. population has improved over the past ... but a new study suggests those gains might soon be ... level off or drop. , If current trends in both ...
... added batches now available, many more to come, NIH director ... stem cell lines have been added to the pool that ... lines will soon be made available, U.S. health officials announced ... lines approved for research funded by the U.S. National Institutes ...
Cached Medicine News:Health News:The Ensign Group Acquires Three Texas Skilled Nursing Facilities 2Health News:The Ensign Group Acquires Three Texas Skilled Nursing Facilities 3Health News:Hennepin Regional Poison Center Designated as an Accredited Poison Control Center 2Health News:Reportlinker Adds Point of Care Diagnostics 2Health News:Reportlinker Adds Point of Care Diagnostics 3Health News:Reportlinker Adds Point of Care Diagnostics 4Health News:Reportlinker Adds Point of Care Diagnostics 5Health News:Reportlinker Adds Point of Care Diagnostics 6Health News:Reportlinker Adds Point of Care Diagnostics 7Health News:Reportlinker Adds Point of Care Diagnostics 8Health News:Reportlinker Adds Point of Care Diagnostics 9Health News:Reportlinker Adds Point of Care Diagnostics 10Health News:Reportlinker Adds Point of Care Diagnostics 11Health News:Reportlinker Adds Point of Care Diagnostics 12Health News:Natural Products Association Issues Statement on New Supplement Safety Campaign 2Health News:Health Gains From Lowered Smoking Rates in Jeopardy 2Health News:Health Gains From Lowered Smoking Rates in Jeopardy 3Health News:U.S. Approves New Stem Cell Lines for Publicly Funded Research 2Health News:U.S. Approves New Stem Cell Lines for Publicly Funded Research 3
Large: 22 x 25 mm, 0.9 x 1.0 inches. With holes. For support of the orbital rim following enucleation. Available in methylmethacrylate....
Designed to insert eye spheres using spring loaded plunger. Polished finish. Overall length: 125 mm, 4.9 inches....
... Size: 3.0 x 7.5 x 80 ... Sponge II line designed by Harvey ... is a closed cell sponge which ... soft with rounded edges to minimize ...
... mm. Storz offers the original Scleral ... A. Lincoff, M.D. The material is ... non-toxic and non-antigenic. Implants are soft ... intrusion. These implants are packaged sterile ...
Medicine Products: